Prescription drug monitoring program in Australia: a qualitative study of stakeholders' experiences and perceptions of a state-wide implementation
Abstract Background Prescription Drug Monitoring Programs (PDMPs) are increasingly implemented across the globe with aims of managing and mitigating risks relating to high-risk prescription medicines. There is limited research focused on identifying strategies or processes for large-scale PDMP imple...
Saved in:
Main Authors: | Emma Tay (Author), Meredith Makeham (Author), Andrew Hargreaves (Author), Tracey-Lea Laba (Author), Melissa Baysari (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Making guidelines for economic evaluations relevant to public health in Australia
by: Tom W. Lung, et al.
Published: (2017) -
Stakeholder perceptions affecting the implementation of teleophthalmology
by: Molly J. E. Snider, et al.
Published: (2022) -
Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia
by: Dimi Hoppe, et al.
Published: (2023) -
Guidance on stakeholder engagement practices to inform the development of area-wide vector control methods.
by: Delphine Thizy, et al.
Published: (2019) -
Patient and Clinician Perceptions of the Pulse Oximeter in a Remote Monitoring Setting for COVID-19: Qualitative Study
by: Andrea Torres-Robles, et al.
Published: (2023)